APO Research
Talk to an analyst

APO RESEARCH · REPORT

Bone Morphogenetic Protein (BMP) 2

Bone morphogenetic proteins (BMPs) are naturally occurring proteins found in the human body. This family of proteins is involved in a myriad of cellular responses. Certain BMPs are osteoinductive—one of the three main categories of bone grafts—and play an active role in bone formation and maintenance.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Bone morphogenetic proteins (BMPs) are naturally occurring proteins found in the human body. This family of proteins is involved in a myriad of cellular responses. Certain BMPs are osteoinductive—one of the three main categories of bone grafts—and play an active role in bone formation and maintenance.

Selected research

Market Analysis & Forecast

Global Bone Morphogenetic Protein (BMP) 2 Market Analysis and Forecast 2026-2032

23 December 2025198 pages

Choose your research edition.

Industry ResearchBone Morphogenetic Protein (BMP) 2 Industry Research Report 2026102 pages · $2,950 USDIndustry Growth & TrendsGlobal Bone Morphogenetic Protein (BMP) 2 Industry Growth and Trends Forecast to 203262 pages · $3,450 USDMarket StructureGlobal Bone Morphogenetic Protein (BMP) 2 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032175 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Bone Morphogenetic Protein (BMP) 2 Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Bone Morphogenetic Protein (BMP) 2 Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

Bone morphogenetic proteins (BMPs) are naturally occurring proteins found in the human body. This family of proteins is involved in a myriad of cellular responses. Certain BMPs are osteoinductive—one of the three main categories of bone grafts—and play an active role in bone formation and maintenance.

According to types, the most proportion of the Bone Morphogenetic Protein (BMP) 2 is Sponge, taking almost 99% sales share of global market in 2020. The most proportion of Bone Morphogenetic Protein (BMP) 2 is used for Spinal Fusion and the proportion is about 66% in 2020. Global market of BMP 2 is extremely intensive. Medtronic, Jiuyuan Gene Engineering and Cellumed are the only 3 companies supplying this product. Furthermore, among these companies, Medtronic takes almost 95% share of global market.

Report Includes

Read the full market overview

This report presents an overview of global market for Bone Morphogenetic Protein (BMP) 2, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Bone Morphogenetic Protein (BMP) 2, also provides the revenue of main regions and countries. Of the upcoming market potential for Bone Morphogenetic Protein (BMP) 2, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Bone Morphogenetic Protein (BMP) 2 revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Bone Morphogenetic Protein (BMP) 2 market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Bone Morphogenetic Protein (BMP) 2 revenue, projected growth trends, production technology, application and end-user industry.

Bone Morphogenetic Protein (BMP) 2 Segment by Company

Medtronic

Jiuyuan Gene Engineering

Cellumed

Bone Morphogenetic Protein (BMP) 2 Segment by Type

Sponge

Gel

Bone Morphogenetic Protein (BMP) 2 Segment by Application

Spinal Fusion

Trauma Surgery

Oral Maxillofacial Surgery

Reconstructive Surgery

Bone Morphogenetic Protein (BMP) 2 Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Bone Morphogenetic Protein (BMP) 2 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Bone Morphogenetic Protein (BMP) 2 and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Bone Morphogenetic Protein (BMP) 2.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Bone Morphogenetic Protein (BMP) 2 in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Bone Morphogenetic Protein (BMP) 2 company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Bone Morphogenetic Protein (BMP) 2 revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Bone Morphogenetic Protein (BMP) 2 Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Sponge Major Player Table 3. Gel Major Player Table 4. Global Bone Morphogenetic Protein (BMP) 2 Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Spinal Fusion Major Player Table 6. Trauma Surgery Major Player Table 7. Oral Maxillofacial Surgery Major Player Table 8. Reconstructive Surgery Major Player Table 9. Bone Morphogenetic Protein (BMP) 2 Industry Trends Table 10. Bone Morphogenetic Protein (BMP) 2 Industry Drivers Table 11. Bone Morphogenetic Protein (BMP) 2 Industry Opportunities and Challenges Table 12. Bone Morphogenetic Protein (BMP) 2 Industry Restraints Table 13. Global Bone Morphogenetic Protein (BMP) 2 Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global Bone Morphogenetic Protein (BMP) 2 Market Size by Region (2021-2026) & (US$ Million) Table 15. Global Bone Morphogenetic Protein (BMP) 2 Market Share by Region (2021-2026) Table 16. Global Bone Morphogenetic Protein (BMP) 2 Market Size by Region (2027-2032) & (US$ Million) Table 17. Global Bone Morphogenetic Protein (BMP) 2 Market Share by Region (2027-2032) Table 18. Global Bone Morphogenetic Protein (BMP) 2 Revenue by Players (US$ Million) & (2021-2026) Table 19. Global Bone Morphogenetic Protein (BMP) 2 Revenue Market Share by Players (2021-2026) Table 20. Global Bone Morphogenetic Protein (BMP) 2 Key Players Ranking, 2024 VS 2025 VS 2026 Table 21. Global Bone Morphogenetic Protein (BMP) 2 Key Players Headquarters & Area Served Table 22. Global Bone Morphogenetic Protein (BMP) 2 Players, Product Type & Application Table 23. Global Bone Morphogenetic Protein (BMP) 2 Players Establishment Date Table 24. Global Players Market Concentration Ratio (CR5 and HHI) Table 25. Global Bone Morphogenetic Protein (BMP) 2 by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 26. Global Bone Morphogenetic Protein (BMP) 2 Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Bone Morphogenetic Protein (BMP) 2 Revenue by Type (2021-2026) & (US$ Million) Table 28. Global Bone Morphogenetic Protein (BMP) 2 Revenue by Type (2027-2032) & (US$ Million) Table 29. Global Bone Morphogenetic Protein (BMP) 2 Revenue Market Share by Type (2021-2026) Table 30. Global Bone Morphogenetic Protein (BMP) 2 Revenue Market Share by Type (2027-2032) Table 31. Global Bone Morphogenetic Protein (BMP) 2 Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Bone Morphogenetic Protein (BMP) 2 Revenue by Application (2021-2026) & (US$ Million) Table 33. Global Bone Morphogenetic Protein (BMP) 2 Revenue by Application (2027-2032) & (US$ Million) Table 34. Global Bone Morphogenetic Protein (BMP) 2 Revenue Market Share by Application (2021-2026) Table 35. Global Bone Morphogenetic Protein (BMP) 2 Revenue Market Share by Application (2027-2032) Table 36. Medtronic Company Information Table 37. Medtronic Business Overview Table 38. Medtronic Bone Morphogenetic Protein (BMP) 2 Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. Medtronic Bone Morphogenetic Protein (BMP) 2 Product Portfolio Table 40. Medtronic Recent Development Table 41. Jiuyuan Gene Engineering Company Information Table 42. Jiuyuan Gene Engineering Business Overview Table 43. Jiuyuan Gene Engineering Bone Morphogenetic Protein (BMP) 2 Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. Jiuyuan Gene Engineering Bone Morphogenetic Protein (BMP) 2 Product Portfolio Table 45. Jiuyuan Gene Engineering Recent Development Table 46. Cellumed Company Information Table 47. Cellumed Business Overview Table 48. Cellumed Bone Morphogenetic Protein (BMP) 2 Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. Cellumed Bone Morphogenetic Protein (BMP) 2 Product Portfolio Table 50. Cellumed Recent Development Table 51. North America Bone Morphogenetic Protein (BMP) 2 Revenue by Type (2021-2026) & (US$ Million) Table 52. North America Bone Morphogenetic Protein (BMP) 2 Revenue by Type (2027-2032) & (US$ Million) Table 53. North America Bone Morphogenetic Protein (BMP) 2 Revenue by Application (2021-2026) & (US$ Million) Table 54. North America Bone Morphogenetic Protein (BMP) 2 Revenue by Application (2027-2032) & (US$ Million) Table 55. North America Bone Morphogenetic Protein (BMP) 2 Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 56. North America Bone Morphogenetic Protein (BMP) 2 Revenue by Country (2021-2026) & (US$ Million) Table 57. North America Bone Morphogenetic Protein (BMP) 2 Revenue by Country (US$ Million) & (2027-2032) Table 58. Europe Bone Morphogenetic Protein (BMP) 2 Revenue by Type (2021-2026) & (US$ Million) Table 59. Europe Bone Morphogenetic Protein (BMP) 2 Revenue by Type (2027-2032) & (US$ Million) Table 60. Europe Bone Morphogenetic Protein (BMP) 2 Revenue by Application (2021-2026) & (US$ Million) Table 61. Europe Bone Morphogenetic Protein (BMP) 2 Revenue by Application (2027-2032) & (US$ Million) Table 62. Europe Bone Morphogenetic Protein (BMP) 2 Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 63. Europe Bone Morphogenetic Protein (BMP) 2 Revenue by Country (2021-2026) & (US$ Million) Table 64. Europe Bone Morphogenetic Protein (BMP) 2 Revenue by Country (US$ Million) & (2027-2032) Table 65. China Bone Morphogenetic Protein (BMP) 2 Revenue by Type (2021-2026) & (US$ Million) Table 66. China Bone Morphogenetic Protein (BMP) 2 Revenue by Type (2027-2032) & (US$ Million) Table 67. China Bone Morphogenetic Protein (BMP) 2 Revenue by Application (2021-2026) & (US$ Million) Table 68. China Bone Morphogenetic Protein (BMP) 2 Revenue by Application (2027-2032) & (US$ Million) Table 69. Asia Bone Morphogenetic Protein (BMP) 2 Revenue by Type (2021-2026) & (US$ Million) Table 70. Asia Bone Morphogenetic Protein (BMP) 2 Revenue by Type (2027-2032) & (US$ Million) Table 71. Asia Bone Morphogenetic Protein (BMP) 2 Revenue by Application (2021-2026) & (US$ Million) Table 72. Asia Bone Morphogenetic Protein (BMP) 2 Revenue by Application (2027-2032) & (US$ Million) Table 73. Asia Bone Morphogenetic Protein (BMP) 2 Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 74. Asia Bone Morphogenetic Protein (BMP) 2 Revenue by Region (US$ Million) & (2021-2026) Table 75. Asia Bone Morphogenetic Protein (BMP) 2 Revenue by Region (US$ Million) & (2027-2032) Table 76. SAMEA Bone Morphogenetic Protein (BMP) 2 Revenue by Type (2021-2026) & (US$ Million) Table 77. SAMEA Bone Morphogenetic Protein (BMP) 2 Revenue by Type (2027-2032) & (US$ Million) Table 78. SAMEA Bone Morphogenetic Protein (BMP) 2 Revenue by Application (2021-2026) & (US$ Million) Table 79. SAMEA Bone Morphogenetic Protein (BMP) 2 Revenue by Application (2027-2032) & (US$ Million) Table 80. SAMEA Bone Morphogenetic Protein (BMP) 2 Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 81. SAMEA Bone Morphogenetic Protein (BMP) 2 Revenue by Country (2021-2026) & (US$ Million) Table 82. SAMEA Bone Morphogenetic Protein (BMP) 2 Revenue by Country (US$ Million) & (2027-2032) Table 83. Research Programs/Design for This Report Table 84. Authors List of This Report Table 85. Secondary Sources Table 86. Primary Sources List of Figures Figure 1. Bone Morphogenetic Protein (BMP) 2 Image Figure 2. Global Bone Morphogenetic Protein (BMP) 2 Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Bone Morphogenetic Protein (BMP) 2 Market Size Share 2021 VS 2025 VS 2032 Figure 4. Sponge Image Figure 5. Gel Image Figure 6. Global Bone Morphogenetic Protein (BMP) 2 Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Bone Morphogenetic Protein (BMP) 2 Market Size Share 2021 VS 2025 VS 2032 Figure 8. Spinal Fusion Image Figure 9. Trauma Surgery Image Figure 10. Oral Maxillofacial Surgery Image Figure 11. Reconstructive Surgery Image Figure 12. Global Bone Morphogenetic Protein (BMP) 2 Market Size (US$ Million) & (2021-2032) Figure 13. Global Bone Morphogenetic Protein (BMP) 2 Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Bone Morphogenetic Protein (BMP) 2 Market Share by Region: 2021 VS 2025 VS 2032 Figure 15. Global Bone Morphogenetic Protein (BMP) 2 Players Revenue Share Top 10 and Top 5 in 2025 Figure 16. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 17. Global Bone Morphogenetic Protein (BMP) 2 Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Bone Morphogenetic Protein (BMP) 2 Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global Bone Morphogenetic Protein (BMP) 2 Revenue Market Share by Type (2021-2032) Figure 20. Global Bone Morphogenetic Protein (BMP) 2 Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Bone Morphogenetic Protein (BMP) 2 Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 22. Global Bone Morphogenetic Protein (BMP) 2 Revenue Market Share by Application (2021-2032) Figure 23. North America Bone Morphogenetic Protein (BMP) 2 Revenue YoY Growth (2021-2032) & (US$ Million) Figure 24. North America Bone Morphogenetic Protein (BMP) 2 Revenue Share by Type (2021-2032) Figure 25. North America Bone Morphogenetic Protein (BMP) 2 Revenue Share by Application (2021-2032) Figure 26. North America Bone Morphogenetic Protein (BMP) 2 Revenue Share by Country (2021-2032) Figure 27. United States Bone Morphogenetic Protein (BMP) 2 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Canada Bone Morphogenetic Protein (BMP) 2 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Mexico Bone Morphogenetic Protein (BMP) 2 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Europe Bone Morphogenetic Protein (BMP) 2 Revenue YoY Growth (2021-2032) & (US$ Million) Figure 31. Europe Bone Morphogenetic Protein (BMP) 2 Revenue Share by Type (2021-2032) Figure 32. Europe Bone Morphogenetic Protein (BMP) 2 Revenue Share by Application (2021-2032) Figure 33. Europe Bone Morphogenetic Protein (BMP) 2 Revenue Share by Country (2021-2032) Figure 34. Germany Bone Morphogenetic Protein (BMP) 2 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. France Bone Morphogenetic Protein (BMP) 2 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. U.K. Bone Morphogenetic Protein (BMP) 2 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Italy Bone Morphogenetic Protein (BMP) 2 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Spain Bone Morphogenetic Protein (BMP) 2 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Russia Bone Morphogenetic Protein (BMP) 2 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Netherlands Bone Morphogenetic Protein (BMP) 2 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Nordic Countries Bone Morphogenetic Protein (BMP) 2 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. China Bone Morphogenetic Protein (BMP) 2 Revenue YoY Growth (2021-2032) & (US$ Million) Figure 43. China Bone Morphogenetic Protein (BMP) 2 Revenue Share by Type (2021-2032) Figure 44. China Bone Morphogenetic Protein (BMP) 2 Revenue Share by Application (2021-2032) Figure 45. Asia Bone Morphogenetic Protein (BMP) 2 Revenue YoY Growth (2021-2032) & (US$ Million) Figure 46. Asia Bone Morphogenetic Protein (BMP) 2 Revenue Share by Type (2021-2032) Figure 47. Asia Bone Morphogenetic Protein (BMP) 2 Revenue Share by Application (2021-2032) Figure 48. Asia Bone Morphogenetic Protein (BMP) 2 Revenue Share by Region (2021-2032) Figure 49. Japan Bone Morphogenetic Protein (BMP) 2 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. South Korea Bone Morphogenetic Protein (BMP) 2 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. India Bone Morphogenetic Protein (BMP) 2 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Australia Bone Morphogenetic Protein (BMP) 2 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Taiwan Bone Morphogenetic Protein (BMP) 2 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Southeast Asia Bone Morphogenetic Protein (BMP) 2 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. SAMEA Bone Morphogenetic Protein (BMP) 2 Revenue YoY Growth (2021-2032) & (US$ Million) Figure 56. SAMEA Bone Morphogenetic Protein (BMP) 2 Revenue Share by Type (2021-2032) Figure 57. SAMEA Bone Morphogenetic Protein (BMP) 2 Revenue Share by Application (2021-2032) Figure 58. SAMEA Bone Morphogenetic Protein (BMP) 2 Revenue Share by Country (2021-2032) Figure 59. Brazil Bone Morphogenetic Protein (BMP) 2 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Argentina Bone Morphogenetic Protein (BMP) 2 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Chile Bone Morphogenetic Protein (BMP) 2 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Colombia Bone Morphogenetic Protein (BMP) 2 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Peru Bone Morphogenetic Protein (BMP) 2 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Saudi Arabia Bone Morphogenetic Protein (BMP) 2 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Israel Bone Morphogenetic Protein (BMP) 2 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. UAE Bone Morphogenetic Protein (BMP) 2 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Turkey Bone Morphogenetic Protein (BMP) 2 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Iran Bone Morphogenetic Protein (BMP) 2 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Egypt Bone Morphogenetic Protein (BMP) 2 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Sponge
  • Gel
Applications
  • Spinal Fusion
  • Trauma Surgery
  • Oral Maxillofacial Surgery
  • Reconstructive Surgery
Companies covered
  • Medtronic
  • Jiuyuan Gene Engineering
  • Cellumed

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Bone Morphogenetic Protein (BMP) 2 Market by Type
  3. 1.2.1 Global Bone Morphogenetic Protein (BMP) 2 Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Sponge
  5. 1.2.3 Gel
  6. 1.3 Bone Morphogenetic Protein (BMP) 2 Market by Application
  7. 1.3.1 Global Bone Morphogenetic Protein (BMP) 2 Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Spinal Fusion
  9. 1.3.3 Trauma Surgery
  10. 1.3.4 Oral Maxillofacial Surgery
  11. 1.3.5 Reconstructive Surgery
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Bone Morphogenetic Protein (BMP) 2 Market Dynamics
  1. 2.1 Bone Morphogenetic Protein (BMP) 2 Industry Trends
  2. 2.2 Bone Morphogenetic Protein (BMP) 2 Industry Drivers
  3. 2.3 Bone Morphogenetic Protein (BMP) 2 Industry Opportunities and Challenges
  4. 2.4 Bone Morphogenetic Protein (BMP) 2 Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Bone Morphogenetic Protein (BMP) 2 Market Perspective (2021-2032)
  2. 3.2 Global Bone Morphogenetic Protein (BMP) 2 Growth Trends by Region
  3. 3.2.1 Global Bone Morphogenetic Protein (BMP) 2 Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Bone Morphogenetic Protein (BMP) 2 Market Size by Region (2021-2026)
  5. 3.2.3 Global Bone Morphogenetic Protein (BMP) 2 Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Bone Morphogenetic Protein (BMP) 2 Revenue by Players
  2. 4.1.1 Global Bone Morphogenetic Protein (BMP) 2 Revenue by Players (2021-2026)
  3. 4.1.2 Global Bone Morphogenetic Protein (BMP) 2 Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Bone Morphogenetic Protein (BMP) 2 Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Bone Morphogenetic Protein (BMP) 2 Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Bone Morphogenetic Protein (BMP) 2 Key Players Headquarters & Area Served
  7. 4.4 Global Bone Morphogenetic Protein (BMP) 2 Players, Product Type & Application
  8. 4.5 Global Bone Morphogenetic Protein (BMP) 2 Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Bone Morphogenetic Protein (BMP) 2 Market CR5 and HHI
  11. 4.6.3 2025 Bone Morphogenetic Protein (BMP) 2 Tier 1, Tier 2, and Tier 3
5 Bone Morphogenetic Protein (BMP) 2 Market Size by Type
  1. 5.1 Global Bone Morphogenetic Protein (BMP) 2 Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Bone Morphogenetic Protein (BMP) 2 Revenue by Type (2021-2032)
  3. 5.3 Global Bone Morphogenetic Protein (BMP) 2 Revenue Market Share by Type (2021-2032)
6 Bone Morphogenetic Protein (BMP) 2 Market Size by Application
  1. 6.1 Global Bone Morphogenetic Protein (BMP) 2 Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Bone Morphogenetic Protein (BMP) 2 Revenue by Application (2021-2032)
  3. 6.3 Global Bone Morphogenetic Protein (BMP) 2 Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Medtronic
  2. 7.1.1 Medtronic Company Information
  3. 7.1.2 Medtronic Business Overview
  4. 7.1.3 Medtronic Bone Morphogenetic Protein (BMP) 2 Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Medtronic Bone Morphogenetic Protein (BMP) 2 Product Portfolio
  6. 7.1.5 Medtronic Recent Developments
  7. 7.2 Jiuyuan Gene Engineering
  8. 7.2.1 Jiuyuan Gene Engineering Company Information
  9. 7.2.2 Jiuyuan Gene Engineering Business Overview
  10. 7.2.3 Jiuyuan Gene Engineering Bone Morphogenetic Protein (BMP) 2 Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Jiuyuan Gene Engineering Bone Morphogenetic Protein (BMP) 2 Product Portfolio
  12. 7.2.5 Jiuyuan Gene Engineering Recent Developments
  13. 7.3 Cellumed
  14. 7.3.1 Cellumed Company Information
  15. 7.3.2 Cellumed Business Overview
  16. 7.3.3 Cellumed Bone Morphogenetic Protein (BMP) 2 Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Cellumed Bone Morphogenetic Protein (BMP) 2 Product Portfolio
  18. 7.3.5 Cellumed Recent Developments
8 North America
  1. 8.1 North America Bone Morphogenetic Protein (BMP) 2 Revenue (2021-2032)
  2. 8.2 North America Bone Morphogenetic Protein (BMP) 2 Revenue by Type (2021-2032)
  3. 8.2.1 North America Bone Morphogenetic Protein (BMP) 2 Revenue by Type (2021-2026)
  4. 8.2.2 North America Bone Morphogenetic Protein (BMP) 2 Revenue by Type (2027-2032)
  5. 8.3 North America Bone Morphogenetic Protein (BMP) 2 Revenue Share by Type (2021-2032)
  6. 8.4 North America Bone Morphogenetic Protein (BMP) 2 Revenue by Application (2021-2032)
  7. 8.4.1 North America Bone Morphogenetic Protein (BMP) 2 Revenue by Application (2021-2026)
  8. 8.4.2 North America Bone Morphogenetic Protein (BMP) 2 Revenue by Application (2027-2032)
  9. 8.5 North America Bone Morphogenetic Protein (BMP) 2 Revenue Share by Application (2021-2032)
  10. 8.6 North America Bone Morphogenetic Protein (BMP) 2 Revenue by Country
  11. 8.6.1 North America Bone Morphogenetic Protein (BMP) 2 Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Bone Morphogenetic Protein (BMP) 2 Revenue by Country (2021-2026)
  13. 8.6.3 North America Bone Morphogenetic Protein (BMP) 2 Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Bone Morphogenetic Protein (BMP) 2 Revenue (2021-2032)
  2. 9.2 Europe Bone Morphogenetic Protein (BMP) 2 Revenue by Type (2021-2032)
  3. 9.2.1 Europe Bone Morphogenetic Protein (BMP) 2 Revenue by Type (2021-2026)
  4. 9.2.2 Europe Bone Morphogenetic Protein (BMP) 2 Revenue by Type (2027-2032)
  5. 9.3 Europe Bone Morphogenetic Protein (BMP) 2 Revenue Share by Type (2021-2032)
  6. 9.4 Europe Bone Morphogenetic Protein (BMP) 2 Revenue by Application (2021-2032)
  7. 9.4.1 Europe Bone Morphogenetic Protein (BMP) 2 Revenue by Application (2021-2026)
  8. 9.4.2 Europe Bone Morphogenetic Protein (BMP) 2 Revenue by Application (2027-2032)
  9. 9.5 Europe Bone Morphogenetic Protein (BMP) 2 Revenue Share by Application (2021-2032)
  10. 9.6 Europe Bone Morphogenetic Protein (BMP) 2 Revenue by Country
  11. 9.6.1 Europe Bone Morphogenetic Protein (BMP) 2 Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Bone Morphogenetic Protein (BMP) 2 Revenue by Country (2021-2026)
  13. 9.6.3 Europe Bone Morphogenetic Protein (BMP) 2 Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Bone Morphogenetic Protein (BMP) 2 Revenue (2021-2032)
  2. 10.2 China Bone Morphogenetic Protein (BMP) 2 Revenue by Type (2021-2032)
  3. 10.2.1 China Bone Morphogenetic Protein (BMP) 2 Revenue by Type (2021-2026)
  4. 10.2.2 China Bone Morphogenetic Protein (BMP) 2 Revenue by Type (2027-2032)
  5. 10.3 China Bone Morphogenetic Protein (BMP) 2 Revenue Share by Type (2021-2032)
  6. 10.4 China Bone Morphogenetic Protein (BMP) 2 Revenue by Application (2021-2032)
  7. 10.4.1 China Bone Morphogenetic Protein (BMP) 2 Revenue by Application (2021-2026)
  8. 10.4.2 China Bone Morphogenetic Protein (BMP) 2 Revenue by Application (2027-2032)
  9. 10.5 China Bone Morphogenetic Protein (BMP) 2 Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Bone Morphogenetic Protein (BMP) 2 Revenue (2021-2032)
  2. 11.2 Asia Bone Morphogenetic Protein (BMP) 2 Revenue by Type (2021-2032)
  3. 11.2.1 Asia Bone Morphogenetic Protein (BMP) 2 Revenue by Type (2021-2026)
  4. 11.2.2 Asia Bone Morphogenetic Protein (BMP) 2 Revenue by Type (2027-2032)
  5. 11.3 Asia Bone Morphogenetic Protein (BMP) 2 Revenue Share by Type (2021-2032)
  6. 11.4 Asia Bone Morphogenetic Protein (BMP) 2 Revenue by Application (2021-2032)
  7. 11.4.1 Asia Bone Morphogenetic Protein (BMP) 2 Revenue by Application (2021-2026)
  8. 11.4.2 Asia Bone Morphogenetic Protein (BMP) 2 Revenue by Application (2027-2032)
  9. 11.5 Asia Bone Morphogenetic Protein (BMP) 2 Revenue Share by Application (2021-2032)
  10. 11.6 Asia Bone Morphogenetic Protein (BMP) 2 Revenue by Country
  11. 11.6.1 Asia Bone Morphogenetic Protein (BMP) 2 Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Bone Morphogenetic Protein (BMP) 2 Revenue by Country (2021-2026)
  13. 11.6.3 Asia Bone Morphogenetic Protein (BMP) 2 Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Bone Morphogenetic Protein (BMP) 2 Revenue (2021-2032)
  2. 12.2 SAMEA Bone Morphogenetic Protein (BMP) 2 Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Bone Morphogenetic Protein (BMP) 2 Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Bone Morphogenetic Protein (BMP) 2 Revenue by Type (2027-2032)
  5. 12.3 SAMEA Bone Morphogenetic Protein (BMP) 2 Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Bone Morphogenetic Protein (BMP) 2 Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Bone Morphogenetic Protein (BMP) 2 Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Bone Morphogenetic Protein (BMP) 2 Revenue by Application (2027-2032)
  9. 12.5 SAMEA Bone Morphogenetic Protein (BMP) 2 Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Bone Morphogenetic Protein (BMP) 2 Revenue by Country
  11. 12.6.1 SAMEA Bone Morphogenetic Protein (BMP) 2 Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Bone Morphogenetic Protein (BMP) 2 Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Bone Morphogenetic Protein (BMP) 2 Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst